the role of LMWH on regulating uterine immune microenviroment and its application in patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040464

Enrollment

Unknown

Registered

2020-11-28

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Case series:low molecular weight heparin

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Two hundred women, aged 25 to 38 years old, receiving IVF because of fallopian tube or semen factor. Embryo implantation failed at least two cycles

Exclusion criteria

Exclusion criteria: endometrium thickness on progesterone conversion day <=7mm or more than 15mm; a history of endocrine or metabolic disorders, ovarian cystectomy, or pathology affecting the endometrial cavity and/or receptivity, Chromosomal abnormalities in at least one spouse and clinical and/or laboratory markers of hereditary or acquired thrombophilia and/or autoimmune disorders.

Design outcomes

Primary

Measure	Time frame
cytokine profiles of uterine;	—

Contacts

Public ContactNiu Zhihong

Ruijin Hospital affilited to Medical school of Shanghai Jiaotong University

chrisnzh@yeah.net+86 15221427862

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026